Salivary features of periodontitis and gingivitis in type 2 diabetes mellitus
- PMID: 39730430
- PMCID: PMC11680937
- DOI: 10.1038/s41598-024-77434-2
Salivary features of periodontitis and gingivitis in type 2 diabetes mellitus
Abstract
Type 2 diabetes mellitus (T2DM) is associated with cellular abnormalities, tissue and organ dysfunctions, and periodontitis. This investigation examined the relationship between the oral microbiome and salivary biomarkers in T2DM patients with or without periodontitis. This cohort (35-80 years) included systemically healthy non-periodontitis (NP; n = 31), T2DM without periodontitis (DWoP; n = 32) and T2DM with periodontitis (DWP; n = 29). The oral microbiome [Operational Taxonomic Units (OTUs)] (16 s rRNA sequencing) and targeted host salivary biomarkers (immunoassays) were assessed. We identified 47 OTUs that were significantly different in abundance between NP samples and any disease subset or between disease subgroups. The most unique microbiome patterns were observed in the DWP group. Differences in genera/species abundance were also observed when T2DM patients were stratified by extent of periodontal inflammation and disease (i.e., generalized versus localized gingivitis/periodontitis). Salivary biomarkers showed significant elevations in MMP-8, MMP-9, resistin, IL-1β, IL-6, IFNα, and BAFF (THFSR13b) comparing generalized to localized periodontitis. Salivary analytes showed significant positive correlations with specific microbiome members, predominantly in DWP patients. Odds ratio analyses reinforced that a panel of biologic markers (IL-6, MMP-8) and bacteria (e.g., Bacteroidetes, Fusobacteria, Spirochaetes) discriminated the severity and extent of periodontal disease in this diabetic population.
Keywords: Diabetes; Inflammation; Microbiome; Periodontitis; Saliva.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures







Similar articles
-
Salivary microbiome and biomarker characteristics of diabetics with periodontitis.Mol Oral Microbiol. 2025 Feb;40(1):37-49. doi: 10.1111/omi.12485. Epub 2024 Oct 1. Mol Oral Microbiol. 2025. PMID: 39351619
-
Biomarker panel discriminates diabetics with and without periodontitis pre- and post-therapy.J Periodontal Res. 2023 Jun;58(3):493-502. doi: 10.1111/jre.13127. Epub 2023 Apr 12. J Periodontal Res. 2023. PMID: 37042710
-
Salivary biomarkers for discriminating periodontitis in the presence of diabetes.J Clin Periodontol. 2021 Feb;48(2):216-225. doi: 10.1111/jcpe.13393. Epub 2020 Nov 17. J Clin Periodontol. 2021. PMID: 33098098
-
Alteration of salivary microbiome in periodontitis with or without type-2 diabetes mellitus and metformin treatment.Sci Rep. 2020 Sep 21;10(1):15363. doi: 10.1038/s41598-020-72035-1. Sci Rep. 2020. PMID: 32958790 Free PMC article.
-
Microbial signatures of health, gingivitis, and periodontitis.Periodontol 2000. 2021 Jun;86(1):57-78. doi: 10.1111/prd.12362. Epub 2021 Mar 10. Periodontol 2000. 2021. PMID: 33690899 Review.
Cited by
-
Glycemic Control, Inflammatory Mediators, and Periodontal Health: A Cross-Sectional Study in Patients with Diabetes.J Clin Med. 2025 Apr 21;14(8):2847. doi: 10.3390/jcm14082847. J Clin Med. 2025. PMID: 40283677 Free PMC article.
References
-
- Geisinger, M. L. et al. Systemic inflammatory biomarkers and their association with periodontal and diabetes-related factors in the diabetes and periodontal therapy trial, A randomized controlled Trial. J. Periodontol.87, 900–913. 10.1902/jop.2016.150727 (2016). - PubMed
-
- Prattichizzo, F. et al. Inflammageing and metaflammation: The yin and yang of type 2 diabetes. Ageing Res. Rev.41, 1–17. 10.1016/j.arr.2017.10.003 (2017). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous